Pfaffikon, Switzerland
LIOM, a Swiss startup founded in 2017, is pioneering in the fields of AI and Biotechnology with its groundbreaking health wearable technology. Under the slogan "The ultimate health wearable. Live consciously.", the company addresses a fundamental issue in health tracking: the absence of biochemical insights.
The company's innovative solution goes beyond existing wearables by offering a continuous, needle-free analysis of biochemical markers, initially focusing on glucose levels. This wearable technology, derived from over 8+ years of research by a team of 50+ scientists, is both calibration-free and non-invasive. Notably, it has been validated with over 130+ subjects and is safeguarded by 23 patent families.
LIOM secured a significant $16.33M in a Series A round on 01 December 2025, with investments from Red Bull Amplifier, Melih Odemis, Alejo Costa Ribalta, and Marc Maurer. The company's vision is advancing towards a product launch in 2028, with pre-orders available in 2027, marking a pivotal step in personal health management. Investors and partners are encouraged to explore collaboration opportunities with this innovative venture.
